Literature DB >> 10481122

Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplication.

G M Campos1, J H Peters, T R DeMeester, S Oberg, P F Crookes, S Tan, S R DeMeester, J A Hagen, C G Bremner.   

Abstract

Laparoscopic Nissen fundoplication has been applied with increasing frequency in the treatment of gastroesophageal reflux disease. The aim of this study was to determine the variables that predict outcome of laparoscopic Nissen fundoplication. A multivariate analysis was performed on data from 199 consecutive patients undergoing laparoscopic Nissen fundoplication. Variables included age, sex, body mass index, primary symptoms, clinical response to acid suppression therapy, erosive esophagitis, 24-hour esophageal pH score, and the percentage of time the esophageal pH was less than 4 on 24-hour pH monitoring, lower esophageal sphincter competence, status of the esophageal body motility, hiatal hernia, carditis, intestinal metaplasia of cardiac epithelium limited to the gastroesophageal junction, and Barrett's esophagus of any length. Clinical outcome was obtained from all patients at a median follow-up of 15 months (range 6 to 74 months) after surgery. One hundred seventy-three patients had an excellent or good outcome (87%) and 26 had a fair or poor outcome. Three factors were significantly predictive of a successful outcome: an abnormal 24-hour pH score (odds ratio = 5.4; 95% confidence interval [CI] = 1. 9-15.3), a typical primary symptom (odds ratio = 5.1; 95% CI = 1. 9-13.6), and a clinical response to acid suppression therapy (odds ratio = 3.3; 95% CI = 1.3-8.7). We conclude that 24-hour pH monitoring provides the strongest outcome predictor of laparoscopic Nissen fundoplication and that outcome is based more on the correct identification of the disease than on its severity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10481122     DOI: 10.1016/s1091-255x(99)80071-7

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  26 in total

1.  Role of esophageal body function in gastroesophageal reflux disease: implications for surgical management.

Authors:  S Rakic; H J Stein; T R DeMeester; R N Hinder
Journal:  J Am Coll Surg       Date:  1997-10       Impact factor: 6.113

2.  Can the combination of symptoms and endoscopy confirm the presence of gastroesophageal reflux disease?

Authors:  L Tefera; M Fein; M P Ritter; C G Bremner; P F Crookes; J H Peters; J A Hagen; T R DeMeester
Journal:  Am Surg       Date:  1997-10       Impact factor: 0.688

3.  Nissen fundoplication prevents shortening of the sphincter during gastric distention.

Authors:  R J Mason; T R DeMeester; R J Lund; J H Peters; P Crookes; M Ritter; M Gadenstätter; J A Hagen
Journal:  Arch Surg       Date:  1997-07

4.  Laparoscopic Nissen fundoplication is an effective treatment for gastroesophageal reflux disease.

Authors:  R A Hinder; C J Filipi; G Wetscher; P Neary; T R DeMeester; G Perdikis
Journal:  Ann Surg       Date:  1994-10       Impact factor: 12.969

5.  Gastroesophageal reflux and pulmonary aspiration: incidence, functional abnormality, and results of surgical therapy.

Authors:  C A Pellegrini; T R DeMeester; L F Johnson; D B Skinner
Journal:  Surgery       Date:  1979-07       Impact factor: 3.982

6.  Complications of gastroesophageal reflux disease. Role of the lower esophageal sphincter, esophageal acid and acid/alkaline exposure, and duodenogastric reflux.

Authors:  H J Stein; A P Barlow; T R DeMeester; R A Hinder
Journal:  Ann Surg       Date:  1992-07       Impact factor: 12.969

7.  The preoperative evaluation of patients considered for laparoscopic antireflux surgery.

Authors:  J P Waring; J G Hunter; M Oddsdottir; J Wo; E Katz
Journal:  Am J Gastroenterol       Date:  1995-01       Impact factor: 10.864

8.  A physiologic approach to laparoscopic fundoplication for gastroesophageal reflux disease.

Authors:  J G Hunter; T L Trus; G D Branum; J P Waring; W C Wood
Journal:  Ann Surg       Date:  1996-06       Impact factor: 12.969

9.  A tailored approach to antireflux surgery.

Authors:  W K Kauer; J H Peters; T R DeMeester; J Heimbucher; A P Ireland; C G Bremner
Journal:  J Thorac Cardiovasc Surg       Date:  1995-07       Impact factor: 5.209

10.  Nissen fundoplication for gastroesophageal reflux disease. Evaluation of primary repair in 100 consecutive patients.

Authors:  T R DeMeester; L Bonavina; M Albertucci
Journal:  Ann Surg       Date:  1986-07       Impact factor: 12.969

View more
  94 in total

Review 1.  Complications of laparoscopic antireflux surgery.

Authors:  D I Watson; A C de Beaux
Journal:  Surg Endosc       Date:  2001-02-06       Impact factor: 4.584

2.  Impedance-pH monitoring on medications does not reliably confirm the presence of gastroesophageal reflux disease in patients referred for antireflux surgery.

Authors:  Marc A Ward; Christy M Dunst; Ezra N Teitelbaum; Valerie J Halpin; Kevin M Reavis; Lee L Swanström; Steven R DeMeester
Journal:  Surg Endosc       Date:  2017-08-04       Impact factor: 4.584

3.  24-h multichannel intraluminal impedance-pH monitoring may be an inadequate test for detecting gastroesophageal reflux in patients with mixed typical and atypical symptoms.

Authors:  Michelle S Han; Michal J Lada; Dylan R Nieman; Andreas Tschoner; Christian G Peyre; Carolyn E Jones; Thomas J Watson; Jeffrey H Peters
Journal:  Surg Endosc       Date:  2014-11-15       Impact factor: 4.584

4.  Treatment of Refractory Gastroesophageal Reflux Disease.

Authors:  Rishi D Naik; Matthew H Meyers; Michael F Vaezi
Journal:  Gastroenterol Hepatol (N Y)       Date:  2020-04

Review 5.  How should Barrett's ulceration be treated?

Authors:  J H Peters; K K Wang
Journal:  Surg Endosc       Date:  2004-01-12       Impact factor: 4.584

Review 6.  Evaluation of gastroesophageal reflux disease.

Authors:  Piero Marco Fisichella; Francisco Schlottmann; Marco G Patti
Journal:  Updates Surg       Date:  2018-07-23

7.  Laparoscopic antireflux surgery: how I do it?

Authors:  Francisco Schlottmann; Fernando A M Herbella; Marco G Patti
Journal:  Updates Surg       Date:  2018-07-23

8.  A one-year follow-up study of endoluminal gastroplication (Endocinch) in GERD patients refractory to proton pump inhibitor therapy.

Authors:  J Arts; T Lerut; P Rutgeerts; D Sifrim; J Janssens; J Tack
Journal:  Dig Dis Sci       Date:  2005-02       Impact factor: 3.199

9.  Gastroesophageal reflux disease and antireflux surgery-what is the proper preoperative work-up?

Authors:  Brian Bello; Marco Zoccali; Roberto Gullo; Marco E Allaix; Fernando A Herbella; Arunas Gasparaitis; Marco G Patti
Journal:  J Gastrointest Surg       Date:  2012-10-23       Impact factor: 3.452

10.  New Approaches to Management of PPI-Refractory Gastroesophageal Reflux Disease.

Authors:  Fehmi Ates; Michael F Vaezi
Journal:  Curr Treat Options Gastroenterol       Date:  2014-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.